Skip to main content
. 2022 Mar 2;9:799488. doi: 10.3389/fcvm.2022.799488

Table 3.

The primary and secondary outcomes.

Non-ECMO
(n = 15)
ECMO
(n = 25)
Unadjusted OR
(95% CI)
P-value
Primary outcome
In-hospital mortality, n (%) 9 (60.0) 13 (52.0) 0.72 (0.20–2.64) 0.623
Secondary outcomes
Severe neurologic complications, n (%) 2 (22.2)a 13 (52.0) 3.79 (0.66–21.96) 0.137
Severe kidney injury, n (%) 5 (35.7)b 11 (44.0) 1.41 (0.37–5.45) 0.614
Major bleeding, n (%) 5 (45.5) 13 (52.0) 2.17 (0.57–8.19) 0.254
ECMO-related complications, n (%) 8 (32.0)

CI, confidence interval; ECMO, veno-arterial extracorporeal membrane oxygenation; OR, odds ratio.

a

Patients who died of unsuccessful resuscitation did not take into account.

b

Patients with end stage renal disease did not take into account.